Differential prognostic impact of type 2 diabetes mellitus in women and men with heart failure with preserved ejection fraction

被引:0
|
作者
Palau, Patricia [1 ,2 ]
Bertomeu-Gonzalez, Vicente [3 ,4 ,5 ]
Sanchis, Juan [5 ,6 ,7 ]
Soler, Meritxell [6 ]
de la Espriella, Rafael [6 ]
Dominguez, Eloy [1 ,2 ]
Santas, Enrique [6 ]
Nunez, Eduardo [6 ]
Chorro, Francisco Javier [6 ,7 ]
Minana, Gema [6 ]
Bayes-Genis, Antoni [5 ,8 ,9 ]
Nunez, Julio [5 ,6 ,7 ]
机构
[1] Hosp Gen Castellon, Serv Cardiol, Castellon de La Plana, Spain
[2] Univ Jaume 1, Unitat Predept Med, Castellon de La Plana, Spain
[3] Hosp Univ San Juan Alicante, Serv Cardiol, Alicante, Spain
[4] Univ Miguel Hernandez, Dept Med Clin, Alicante, Spain
[5] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain
[6] Hosp Clin Univ, Serv Cardiol, INCLIVA, Valencia, Spain
[7] Univ Valencia, Dept Med, Valencia, Spain
[8] Hosp Badalona Germans Trias & Pujol, Serv Cardiol, Unidad Insuficiencia Cardiaca, Barcelona, Spain
[9] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2020年 / 73卷 / 06期
关键词
Heart failure with preserved ejection fraction; Sex differences; Women; Diabetes mellitus; Mortality; EUROPEAN-SOCIETY; ESC GUIDELINES; TASK-FORCE; DIAGNOSIS; CARDIOMYOPATHY; COLLABORATION; ASSOCIATION; PREVALENCE; OUTCOMES; GENDER;
D O I
10.1016/j.recesp.2019.08.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objectives: Type 2 diabetes mellitus (DM2) is a common comorbidity in patients with heart failure (HF) with preserved ejection fraction (HFpEF). Previous studies have shown that diabetic women are at higher risk of developing HF than men. However, the long-term prognosis of diabetic HFpEF patients by sex has not been extensively explored. In this study, we aimed to evaluate the differential impact of DM2 on all-cause mortality in men vs women with HFpEF after admission for acute HF. Methods: We prospectively included 1019 consecutive HFpEF patients discharged after admission for acute HF in a single tertiary referral hospital. Multivariate Cox regression analysis was used to evaluate the interaction between sex and DM2 regarding the risk of long-term all-cause mortality. Risk estimates were calculated as hazard ratios (HR). Results: The mean age of the cohort was 75.6 +/- 9.5 years and 609 (59.8%) were women. The proportion of DM2 was similar between sexes (45.1% vs 49.1%, P = .211). At a median (interquartile range) follow-up of 3.6 (1-4-6.8) years, 646 (63.4%) patients died. After adjustment for risk factors, comorbidities, biomarkers, echo parameters and treatment at discharge, multivariate analysis showed a differential prognostic effect of DM2 (P value for interaction = .007). DM2 was associated with a higher risk of all-cause mortality in women (HR, 1.77; 95%CI, 1.41-2.21; P < .001) but not in men (HR, 1.23; 95%CI, 0.94-1.61; P = .127). Conclusions: After an episode of acute HF in HFpEF patients, DM2 confers a higher risk of mortality in women. Further studies evaluating the impact of DM2 in women with HFpEF are warranted. (C) 2019 Sociedad Espanola de Cardiologi ' a. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:463 / 470
页数:8
相关论文
共 50 条
  • [31] Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus
    Ejiri, Kentaro
    Miyoshi, Toru
    Kihara, Hajime
    Hata, Yoshiki
    Nagano, Toshihiko
    Takaishi, Atsushi
    Toda, Hironobu
    Nanba, Seiji
    Nakamura, Yoichi
    Akagi, Satoshi
    Sakuragi, Satoru
    Minagawa, Taro
    Kawai, Yusuke
    Nishii, Nobuhiro
    Fuke, Soichiro
    Yoshikawa, Masaki
    Nakamura, Kazufumi
    Ito, Hiroshi
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (16):
  • [32] Impact of dapagliflosin on apelin serum levels in type 2 diabetes mellitus patients depending on occurrence of heart failure with preserved ejection fraction
    Berezin, A. Alexander E.
    Fushtey, I. M.
    Berezin, A. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 13 - 14
  • [33] Prognostic role of vascular endothelial growth factor- A in patients with chronic heart failure with preserved ejection fraction and type 2 diabetes mellitus
    Ovrakh, T. Tamara
    Serik, S.
    Chenchik, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 81 - 81
  • [34] Prognostic Impact of Comorbidities on Mortality in Patients with Heart failure and Preserved Ejection Fraction vs Heart Failure with Reduced Ejection Fraction
    Ather, Sameer
    Chan, Wenyaw
    Bozkurt, Biykem
    Aguilar, David
    Ramasubbu, Kumudha
    Deswal, Anita
    CIRCULATION, 2010, 122 (21)
  • [35] Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes
    Mordi, Ify R.
    Tee, Aaron
    Palmer, Colin N.
    McCrimmon, Rory J.
    Doney, Alexander S. F.
    Lang, Chim C.
    ESC HEART FAILURE, 2020, 7 (03): : 1168 - 1177
  • [36] Comparison of morbidity in women versus men with heart failure and preserved ejection fraction
    Deswal, A
    Bozkurt, B
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (08): : 1228 - 1231
  • [37] Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction
    Chimura, Misato
    Wang, Xiaowen
    Jhund, Pardeep S.
    Henderson, Alasdair D.
    Claggett, Brian L.
    Desai, Akshay S.
    Fonseca, Candida
    Goncalvesova, Eva
    Katova, Tzvetana
    Mueller, Katharina
    Glasauer, Andrea
    Rohwedder, Katja
    Viswanathan, Prabhakar
    Nodari, Savina
    Lam, Carolyn S. P.
    Saldarriaga, Clara Ines
    Senni, Michele
    Sharma, Kavita
    Voors, Adriaan A.
    Zannad, Faiez
    Pitt, Bertram
    Vardeny, Orly
    Vaduganathan, Muthiah
    Solomon, Scott D.
    Mcmurray, John J. V.
    JAMA CARDIOLOGY, 2024,
  • [38] Heart failure with preserved ejection fraction: Similarities and differences between women and men
    Pepine, Carl J.
    Merz, C. Noel Bairey
    El Hajj, Stephanie
    Ferdinand, Keith C.
    Hamilton, Michele A.
    Lindley, Kathryn J.
    Nelson, Michael D.
    Quesada, Odayme
    Wenger, Nanette K.
    Fleg, Jerome L.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 304 : 101 - 108
  • [39] Prevalence prognostic impact of diabetes in heart failure with preserved, mid-range and reduced ejection fraction
    Jang, S. Y. Se Yong
    Park, B. E.
    Park, Y. J.
    Bae, M. H.
    Lee, J. H.
    Yang, D. H.
    Park, H. S.
    Cho, Y.
    Chae, S. C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 445 - 445
  • [40] Prognostic impact of heart failure in patients with diabetes, chronic kidney disease, anemia and preserved ejection fraction
    Kraigher-Krainer, E.
    Gupta, D. K.
    Solomon, S. D.
    Anand, I.
    Desai, A. S.
    Hilton, T.
    McMurray, J.
    Mielniczuk, L.
    Toto, R. D.
    Lewis, E. F.
    EUROPEAN HEART JOURNAL, 2012, 33 : 641 - 641